Advertisement
New Zealand markets close in 4 hours 25 minutes
  • NZX 50

    11,792.41
    -43.63 (-0.37%)
     
  • NZD/USD

    0.5898
    -0.0007 (-0.12%)
     
  • NZD/EUR

    0.5542
    -0.0003 (-0.05%)
     
  • ALL ORDS

    7,818.50
    -80.40 (-1.02%)
     
  • ASX 200

    7,563.10
    -79.00 (-1.03%)
     
  • OIL

    82.50
    -0.23 (-0.28%)
     
  • GOLD

    2,388.90
    -9.10 (-0.38%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • NIKKEI 225

    37,521.26
    -558.44 (-1.47%)
     
  • NZD/JPY

    91.1360
    -0.1180 (-0.13%)
     

Why Eli Lilly Stock Climbed Today

Why Eli Lilly Stock Climbed Today

Shares of Eli Lilly (NYSE: LLY) rose on Monday after the U.S. Food and Drug Administration (FDA) approved the pharmaceutical giant's new diabetes treatment, tirzepatide. As of 1:50 p.m. ET, Eli Lilly's stock price was up more than 3%. A phase 3 clinical trial showed tirzepatide to reduce A1C -- a key measure of average blood sugar levels -- better than existing treatment options.